MediWound (MDWD) Other financing activities (2013 - 2026)
MediWound (MDWD) posted Other financing activities of $767000.0 for Q2 2026, up 12683.33% on a QoQ basis from $6000.0 in Q4 2025, and down 8.47% year-over-year from $838000.0 in Q2 2025.
Analysis
MediWound (MDWD) Other financing activities (2013 - 2026) Analysis & Trends
MediWound has reported Other financing activities for 11 years, with the latest figure at $767000.0 in Q2 2026.
- On a quarterly basis, Other financing activities fell 8.47% year-over-year to $767000.0 in Q2 2026; TTM through Jun 2026 was $4.4 million, a 183.86% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 200.0% from the prior year.
- Other financing activities was $767000.0 for Q2 2026 at MediWound, up from $6000.0 in the prior quarter.
- The five-year high for Other financing activities was $25.2 million in Q1 2023, with the low at -$24.9 million in Q4 2023.
- Average Other financing activities over 5 years is $2.4 million, with a median of $767000.0 recorded in 2026.
- The sharpest annual moves came in 2023 and 2025: Other financing activities slumped 1092.79% in 2023, then soared 654.95% in 2025.
- Over 5 years, Other financing activities stood at $2.5 million in 2022, then plunged by 1092.79% to -$24.9 million in 2023, then jumped by 102.41% to $600000.0 in 2024, then sank by 99.0% to $6000.0 in 2025, then soared by 12683.33% to $767000.0 in 2026.
- The last three Other financing activities figures came in at $767000.0 (Q2 2026), $6000.0 (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | MediWound | 156.09 Mn | 120.75 Mn | 337,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 767,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 2.79 Mn |
| Jun 30, 2025 | 838,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 111,000.00 |
| Mar 31, 2024 | 499,000.00 |
| Dec 31, 2023 | -24.91 Mn |
| Jun 30, 2023 | -248,000.00 |
| Mar 31, 2023 | 25.16 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Sep 30, 2022 | 12.05 Mn |
| Mar 31, 2022 | 10.42 Mn |
| Dec 31, 2021 | -4.00 Mn |
| Jun 30, 2021 | -4,000.00 |
| Dec 31, 2017 | -136,000.00 |
| Sep 30, 2017 | 5,000.00 |
| Jun 30, 2017 | 2,000.00 |
| Dec 31, 2016 | 5,000.00 |
| Sep 30, 2016 | 2,000.00 |